• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种计算方法,用于鉴定针对新型冠状病毒 SARS-CoV-2 的潜在新型抑制剂。

A Computational Approach to Identify Potential Novel Inhibitors against the Coronavirus SARS-CoV-2.

机构信息

Department of Pharmaceutical Chemistry, University of Vienna, Althanstraße 14, A-1090, Vienna, Austria.

出版信息

Mol Inform. 2020 Oct;39(10):e2000090. doi: 10.1002/minf.202000090. Epub 2020 Jul 28.

DOI:10.1002/minf.202000090
PMID:32721082
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7583376/
Abstract

The current pandemic threat of COVID-19, caused by the novel coronavirus SARS-CoV-2, not only gives rise to a high number of deaths around the world but also has immense consequences for the worldwide health systems and global economy. Given the fact that this pandemic is still ongoing and there are currently no drugs or vaccines against this novel coronavirus available, this in silico study was conducted to identify a potential novel SARS-CoV-2-inhibitor. Two different approaches were pursued: 1) The Docking Consensus Approach (DCA) is a novel approach, which combines molecular dynamics simulations with molecular docking. 2) The Common Hits Approach (CHA) in contrast focuses on the combination of the feature information of pharmacophore modeling and the flexibility of molecular dynamics simulations. The application of both methods resulted in the identification of 10 compounds with high coronavirus inhibition potential.

摘要

当前由新型冠状病毒 SARS-CoV-2 引起的 COVID-19 大流行不仅在全球范围内导致了大量死亡,而且对全球卫生系统和全球经济也产生了巨大影响。鉴于这种大流行仍在继续,目前尚无针对这种新型冠状病毒的药物或疫苗,因此进行了这项计算机模拟研究以鉴定一种潜在的新型 SARS-CoV-2 抑制剂。采用了两种不同的方法:1)对接共识方法(DCA)是一种新方法,它将分子动力学模拟与分子对接相结合。2)相反,常见命中方法(CHA)侧重于组合药效团建模的特征信息和分子动力学模拟的灵活性。这两种方法的应用都确定了具有高冠状病毒抑制潜力的 10 种化合物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/7583376/a03a149658b2/MINF-39-2000090-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/7583376/e14e9899938b/MINF-39-2000090-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/7583376/e7093e044bac/MINF-39-2000090-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/7583376/7da7fa03cf41/MINF-39-2000090-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/7583376/6d154f935ed5/MINF-39-2000090-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/7583376/a03a149658b2/MINF-39-2000090-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/7583376/e14e9899938b/MINF-39-2000090-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/7583376/e7093e044bac/MINF-39-2000090-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/7583376/7da7fa03cf41/MINF-39-2000090-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/7583376/6d154f935ed5/MINF-39-2000090-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e4/7583376/a03a149658b2/MINF-39-2000090-g005.jpg

相似文献

1
A Computational Approach to Identify Potential Novel Inhibitors against the Coronavirus SARS-CoV-2.一种计算方法,用于鉴定针对新型冠状病毒 SARS-CoV-2 的潜在新型抑制剂。
Mol Inform. 2020 Oct;39(10):e2000090. doi: 10.1002/minf.202000090. Epub 2020 Jul 28.
2
Discovery of New Hydroxyethylamine Analogs against 3CL Protein Target of SARS-CoV-2: Molecular Docking, Molecular Dynamics Simulation, and Structure-Activity Relationship Studies.新型羟乙胺类 SARS-CoV-2 3CL 蛋白酶抑制剂的发现:基于分子对接、分子动力学模拟和构效关系研究。
J Chem Inf Model. 2020 Dec 28;60(12):5754-5770. doi: 10.1021/acs.jcim.0c00326. Epub 2020 Jun 18.
3
Drugs Repurposing Using QSAR, Docking and Molecular Dynamics for Possible Inhibitors of the SARS-CoV-2 M Protease.利用定量构效关系、对接和分子动力学对严重急性呼吸综合征冠状病毒2 M蛋白酶的潜在抑制剂进行药物再利用研究
Molecules. 2020 Nov 6;25(21):5172. doi: 10.3390/molecules25215172.
4
Screening of Severe Acute Respiratory Syndrome Coronavirus 2 RNA-Dependent RNA Polymerase Inhibitors Using Computational Approach.采用计算方法筛选严重急性呼吸综合征冠状病毒 2 依赖 RNA 的 RNA 聚合酶抑制剂。
J Comput Biol. 2021 Dec;28(12):1228-1247. doi: 10.1089/cmb.2020.0639. Epub 2021 Nov 29.
5
Iterated Virtual Screening-Assisted Antiviral and Enzyme Inhibition Assays Reveal the Discovery of Novel Promising Anti-SARS-CoV-2 with Dual Activity.迭代虚拟筛选辅助抗病毒和酶抑制检测揭示了具有双重活性的新型有希望的抗 SARS-CoV-2 药物的发现。
Int J Mol Sci. 2021 Aug 22;22(16):9057. doi: 10.3390/ijms22169057.
6
Computational discovery of dual potential inhibitors of SARS-CoV-2 spike/ACE2 and M: 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics.计算发现 SARS-CoV-2 刺突/ACE2 和 M 的双重潜在抑制剂:3D 药效团、基于对接的虚拟筛选、量子力学和分子动力学。
Eur Biophys J. 2024 Aug;53(5-6):277-298. doi: 10.1007/s00249-024-01713-z. Epub 2024 Jun 21.
7
Targeting SARS-CoV-2 Main Protease: A Computational Drug Repurposing Study.靶向 SARS-CoV-2 主蛋白酶:一项计算药物再利用研究。
Arch Med Res. 2021 Jan;52(1):38-47. doi: 10.1016/j.arcmed.2020.09.013. Epub 2020 Sep 17.
8
Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.基于甘草酸的抑制剂对新型冠状病毒2型(SARS-CoV-2)ACE2宿主受体的分子筛选
J Mol Model. 2021 Jun 24;27(7):206. doi: 10.1007/s00894-021-04816-y.
9
Synthesis and Identification of Novel Potential Molecules Against COVID-19 Main Protease Through Structure-Guided Virtual Screening Approach.通过基于结构的虚拟筛选方法合成和鉴定新型抗 COVID-19 主蛋白酶的潜在分子。
Appl Biochem Biotechnol. 2021 Nov;193(11):3602-3623. doi: 10.1007/s12010-021-03615-8. Epub 2021 Jul 29.
10
Potential Novel Thioether-Amide or Guanidine-Linker Class of SARS-CoV-2 Virus RNA-Dependent RNA Polymerase Inhibitors Identified by High-Throughput Virtual Screening Coupled to Free-Energy Calculations.通过高通量虚拟筛选与自由能计算相结合,鉴定出新型硫醚-酰胺或胍基连接子类 SARS-CoV-2 病毒 RNA 依赖性 RNA 聚合酶抑制剂。
Int J Mol Sci. 2021 Oct 15;22(20):11143. doi: 10.3390/ijms222011143.

引用本文的文献

1
Novel Drug Design for Treatment of COVID-19: A Systematic Review of Preclinical Studies.用于治疗新冠肺炎的新型药物设计:临床前研究的系统综述
Can J Infect Dis Med Microbiol. 2022 Sep 25;2022:2044282. doi: 10.1155/2022/2044282. eCollection 2022.
2
Pharmacophore-Based Virtual Screening and Experimental Validation of Pyrazolone-Derived Inhibitors toward Janus Kinases.基于药效团的吡唑啉酮衍生的Janus激酶抑制剂虚拟筛选及实验验证
ACS Omega. 2022 Sep 6;7(37):33548-33559. doi: 10.1021/acsomega.2c04535. eCollection 2022 Sep 20.
3
Methodology-Centered Review of Molecular Modeling, Simulation, and Prediction of SARS-CoV-2.

本文引用的文献

1
Addendum: Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan, China.附录:根据中国武汉的传播动态估计COVID-19的临床严重程度。
Nat Med. 2020 Jul;26(7):1149-1150. doi: 10.1038/s41591-020-0920-6.
2
Research and Development on Therapeutic Agents and Vaccines for COVID-19 and Related Human Coronavirus Diseases.新型冠状病毒肺炎及相关人类冠状病毒疾病治疗药物和疫苗的研发
ACS Cent Sci. 2020 Mar 25;6(3):315-331. doi: 10.1021/acscentsci.0c00272. Epub 2020 Mar 12.
3
Protein Structure and Sequence Reanalysis of 2019-nCoV Genome Refutes Snakes as Its Intermediate Host and the Unique Similarity between Its Spike Protein Insertions and HIV-1.
基于方法的 SARS-CoV-2 分子建模、模拟和预测综述。
Chem Rev. 2022 Jul 13;122(13):11287-11368. doi: 10.1021/acs.chemrev.1c00965. Epub 2022 May 20.
4
In Silico Drug Repositioning to Target the SARS-CoV-2 Main Protease as Covalent Inhibitors Employing a Combined Structure-Based Virtual Screening Strategy of Pharmacophore Models and Covalent Docking.基于药效团模型和共价对接的联合结构虚拟筛选策略,针对 SARS-CoV-2 主要蛋白酶进行计算机药物重定位以作为共价抑制剂。
Int J Mol Sci. 2022 Apr 3;23(7):3987. doi: 10.3390/ijms23073987.
5
Molecular Docking as a Potential Approach in Repurposing Drugs Against COVID-19: a Systematic Review and Novel Pharmacophore Models.分子对接作为一种重新利用药物对抗 COVID-19 的潜在方法:系统综述与新型药效团模型
Curr Pharmacol Rep. 2022;8(3):212-226. doi: 10.1007/s40495-022-00285-w. Epub 2022 Apr 1.
6
Structure- and Ligand-Based Studies towards the Repurposing of Marine Bioactive Compounds to Target SARS-CoV-2.基于结构和配体的研究:海洋生物活性化合物重新用于靶向严重急性呼吸综合征冠状病毒2
Arab J Chem. 2021 Apr;14(4):103092. doi: 10.1016/j.arabjc.2021.103092. Epub 2021 Feb 25.
7
Haste makes waste: A critical review of docking-based virtual screening in drug repurposing for SARS-CoV-2 main protease (M-pro) inhibition.欲速则不达:基于对接的虚拟筛选在 SARS-CoV-2 主蛋白酶(M-pro)抑制药物再利用中的批判性评价。
Med Res Rev. 2022 Mar;42(2):744-769. doi: 10.1002/med.21862. Epub 2021 Oct 26.
8
Repurposing the inhibitors of COVID-19 key proteins through molecular docking approach.通过分子对接方法重新利用新冠病毒关键蛋白抑制剂。
Process Biochem. 2021 Nov;110:216-222. doi: 10.1016/j.procbio.2021.08.015. Epub 2021 Aug 17.
9
Screening of Natural Phytocompounds Towards Identification of Potential Lead Compounds to Treat COVID-19.筛选天然植物化合物以鉴定治疗新冠肺炎的潜在先导化合物。
Front Mol Biosci. 2021 Jul 5;8:637122. doi: 10.3389/fmolb.2021.637122. eCollection 2021.
10
Main protease inhibitors and drug surface hotspots for the treatment of COVID-19: A drug repurposing and molecular docking approach.用于治疗新冠肺炎的主要蛋白酶抑制剂和药物表面热点:一种药物再利用和分子对接方法。
Biomed Pharmacother. 2021 Aug;140:111742. doi: 10.1016/j.biopha.2021.111742. Epub 2021 May 18.
2019-nCoV 基因组的蛋白结构和序列再分析否定了蛇类是其中间宿主,以及其刺突蛋白插入与 HIV-1 之间的独特相似性。
J Proteome Res. 2020 Apr 3;19(4):1351-1360. doi: 10.1021/acs.jproteome.0c00129. Epub 2020 Mar 24.
4
COVID-19 in Italy: momentous decisions and many uncertainties.意大利的新冠疫情:重大决策与诸多不确定性。
Lancet Glob Health. 2020 May;8(5):e641-e642. doi: 10.1016/S2214-109X(20)30110-8. Epub 2020 Mar 18.
5
Case-Fatality Risk Estimates for COVID-19 Calculated by Using a Lag Time for Fatality.使用病死率滞后时间估算 COVID-19 的病死率风险估计。
Emerg Infect Dis. 2020 Jun;26(6):1339-1441. doi: 10.3201/eid2606.200320. Epub 2020 Jun 17.
6
The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2.严重急性呼吸综合征相关冠状病毒:将 2019-nCoV 进行分类并命名为 SARS-CoV-2。
Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.
7
A Novel Coronavirus from Patients with Pneumonia in China, 2019.2019 年中国肺炎患者中的一种新型冠状病毒。
N Engl J Med. 2020 Feb 20;382(8):727-733. doi: 10.1056/NEJMoa2001017. Epub 2020 Jan 24.
8
TTClust: A Versatile Molecular Simulation Trajectory Clustering Program with Graphical Summaries.TTClust:一个功能多样的分子模拟轨迹聚类程序,带有图形摘要。
J Chem Inf Model. 2018 Nov 26;58(11):2178-2182. doi: 10.1021/acs.jcim.8b00512. Epub 2018 Oct 30.
9
Database resources of the National Center for Biotechnology Information.国家生物技术信息中心数据库资源。
Nucleic Acids Res. 2018 Jan 4;46(D1):D8-D13. doi: 10.1093/nar/gkx1095.
10
Exploring the stability of ligand binding modes to proteins by molecular dynamics simulations.通过分子动力学模拟探索配体与蛋白质结合模式的稳定性。
J Comput Aided Mol Des. 2017 Feb;31(2):201-211. doi: 10.1007/s10822-016-0005-2. Epub 2017 Jan 10.